Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

MGI Tech

Explore full profile

Providing real-time, comprehensive, life-long solutions, its mission is to advance life science tools and lead digital health innovation

Shenzhen, ChinaFounded 2016Biotech & Life Sciences
Valuation $2.5–5B Last recorded · 2020
Revenue $100–500M Latest reported FY
Headcount 1–2k Current team size
Total funding $1–2.5B Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for MGI Tech and the history behind them.

About MGI Tech

MGI Tech, a subsidiary of the BGI Group, specializes in the development and manufacturing of high-throughput gene sequencing machines and related technologies. The company provides core tools for life science research, including genetic sequencers, laboratory automation systems, and robotic ultrasound systems.

Read full description

Their primary market includes academic institutions, pharmaceutical companies, and clinical laboratories. MGI Tech's business model is centered on the sale of these instruments and the associated reagents and consumables required for their operation. A key technology is their proprietary DNBSEQ™, which is designed to improve the efficiency and productivity of sequencing. The company also offers solutions for pathogen detection and single-cell omics, expanding its reach into public health and specialized research areas. By providing a range of products from library preparation kits to large-scale sequencing platforms, MGI Tech serves a broad spectrum of the genomics market.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Shenzhen, China
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning MGI Tech.

See all news

Investors

13 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • CITIC Securities
  • Green Pine Capital
  • Orient Securities Capital Investment
  • GF Xinde Investment
  • CITIC PE
  • IDG Capital
  • Huaxing Alpha
  • Huatai Zijin Investment

Series B and later5 investors entered at this stage

  • Huatai Zijin Investment
  • CITIC PE
  • Huaxing Alpha
  • GF Xinde Investment
  • IDG Capital
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
43 countries with
team presence
🇨🇳 China29%
🇧🇷 Brazil6.1%
🇦🇺 Australia5.7%
🇩🇪 Germany5.7%
🇸🇬 Singapore5.4%
Top 5 of 43 shown

Patents

Estimated portfolio value
$174M

1,248 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about MGI Tech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MGI Tech on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.